Nephrology in Cambridge, MA
5 verified nephrology doctors in Cambridge.
Nephrologists treat kidney disease, high blood pressure, and disorders of fluid and electrolyte balance.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Massachusetts Board of Registration in Medicine
Dr. Leorah Ross, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Stephanie Lear, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Margaret Mclaughlin, MD
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Rekha Abichandani, MD
Nephrology
CMS Open Payments· $7,785 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$7,785
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 10,935 nephrology doctors we've analyzed, about 59% received any industry payment (median $286 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US nephrology doctors.
Payments to Rekha Abichandani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Amanda O'Donnell, DO
Nephrology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.